oppn parties Covaxin To Be Produced By Other Vaccine Manufacturers

News Snippets

  • The Indian envoy in Bangladesh was summoned by the country's government over the breach in the Bangladesh mission in Agartala
  • Bank account to soon have 4 nominees each
  • TMC and SP stayed away from the INDIA bloc protest over the Adani issue in the Lok Sabha
  • Delhi HC stops the police from arresting Nadeem Khan over a viral video which the police claimed promoted 'enmity'. Court says 'India's harmony not so fragile'
  • Trafiksol asked to refund IPO money by Sebi on account of alleged fraud
  • Re goes down to 84.76 against the USD but ends flat after RBI intervenes
  • Sin goods like tobacco, cigarettes and soft drinks likely to face 35% GST in the post-compensation cess era
  • Bank credit growth slows to 11% (20.6% last year) with retail oans also showing a slowdown
  • Stock markets continue their winning streak on Tuesday: Sensex jumps 597 points to 80845 and Nifty gains 181 points to 24457
  • Asian junior hockey: Defending champions India enter the finals by beating Malaysia 3-1, to play Pakistan for the title
  • Chess World title match: Ding Liren salvages a sraw in the 7th game which he almost lost
  • Experts speculate whether Ding Liren wants the world title match against D Gukesh to go into tie-break after he let off Gukesh easily in the 5th game
  • Tata Memorial Hospital and AIIMS have severely criticized former cricketer and Congress leader Navjot Singh Sidhu for claiming that his wife fought back cancer with home remedies like haldi, garlic and neem. The hospitals warned the public for not going for such unproven remedies and not delaying treatment as it could prove fatal
  • 3 persons died and scores of policemen wer injured when a survey of a mosque in Sambhal near Bareilly in UP turned violent
  • Bangladesh to review power pacts with Indian companies, including those of the Adani group
D Gukesh is the new chess world champion at 18, the first teen to wear the crown. Capitalizes on an error by Ding Liren to snatch the crown by winning the final game g
oppn parties
Covaxin To Be Produced By Other Vaccine Manufacturers

By Linus Garg
First publised on 2021-05-14 01:29:06

About the Author

Sunil Garodia Linus tackles things head-on. He takes sides in his analysis and it fits excellently with our editorial policy. No 'maybe's' and 'allegedly' for him, only things in black and white.

Nearly a month after Prime Minister Modi first talked about using the entire vaccine manufacturing capacity in the country to produce the Covid vaccines and former prime minister and Congress leader Dr Manmohan Singh urged the government to invoke compulsory licensing provisions to allow all capable manufacturers to produce the vaccines, the government has invited all vaccine manufacturers in India to produce the indigenously developed (by ICMR and Bharat Biotech) Covaxin that is currently being made only by Bharat Biotech. NITI Aayog member Dr V K Paul said that Bharat Biotech has agreed to this arrangement.

This is a good move as it will help the government procure more doses from additional and captive sources at an attractive price. But it is regrettable that it took the government one month to take this decision. Under normal circumstances, such delays are part and parcel of both governance and corporate negotiations. But when there is a pandemic situation, the Disaster Management Act is in force and vaccines are in short supply threatening to derail the vaccine drive, one thinks decisions need to be taken on war footing. Such delays cannot be condoned in these troubled times.

But there is a stumbling block in the process as not all vaccine manufacturers in India have a BSL3 (Biosafety Level 3) lab which is necessary to inactivate a live virus in order to produce the Covid vaccines. The government must help those vaccine manufacturers who do not have this facility to get the lab up and running as fast as possible. It must provide them with funds and if import of equipment is required, it must allow and facilitate that. It must also assist them in getting the imported raw materials and provide them advance payments to fund their working capital requirements. Hopefully, once these manufacturers start production in full, there will be no vaccine shortage in India.